about
Cancer Clocks Out for Lunch: Disruption of Circadian Rhythm and Metabolic Oscillation in CancerMetabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic AgentsPancreatic cancer from bench to bedside: molecular pathways and treatment optionsMolecular Imaging of Metabolic Reprograming in Mutant IDH CellsGenetics and biology of pancreatic ductal adenocarcinomaLeaving the lysosome behind: novel developments in autophagy inhibitionPancreatic Cancer Metabolism: Breaking It Down to Build It Back UpKRAS as a Therapeutic TargetMacropinocytosis Exploitation by Cancers and Cancer TherapeuticsRAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?Septins promote macropinosome maturation and traffic to the lysosome by facilitating membrane fusion.Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis.High-content, full genome siRNA screen for regulators of oncogenic HRAS-driven macropinocytosis.K-Ras Activation Induces Differential Sensitivity to Sulfur Amino Acid Limitation and Deprivation and to Oxidative and Anti-Oxidative Stress in Mouse FibroblastsAn Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.Mechanisms of Selective Autophagy in Normal Physiology and CancerTherapeutic Approaches to RAS Mutation.A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?Direct Modulation of Small GTPase Activity and Function.The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?Modeling K-Ras-driven lung adenocarcinoma in mice: preclinical validation of therapeutic targets.Targeting metabolic reprogramming in KRAS-driven cancers.K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?The renewed battle against RAS-mutant cancers.Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer.Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics.Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.Increasing rigor in NMR-based metabolomics through validated and open source tools.Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.Transformation by different oncogenes relies on specific metabolic adaptations.Integrated analysis of mRNA and miRNA expression in HeLa cells expressing low levels of Nucleolin.Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer.Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation.Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer.The Future of Radiobiology.Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.Oncogene-Driven Metabolic Alterations in Cancer.Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets.Evolutionary biology of high-risk multiple myeloma.
P2860
Q26738550-8E252EED-CF99-442A-AF6E-FC58AA89CBD4Q26740567-949D72D5-F42B-455F-B760-2D9D0C317018Q26747524-6BA5DD44-5171-4F1D-A35F-3958131C39BBQ26750861-0B7E9E85-9FA4-42CA-B16D-D6E0FC1E4DCFQ26765438-70079F8E-2541-4C4A-BF5D-5FE3B2B302EEQ26774549-5E390D6A-F1C2-4738-A49B-5AAACA3965F6Q26780372-BF182744-8F21-4549-BC39-3552CDA3D06AQ27007866-7B7135E8-5C7A-46DD-9560-2E71C01593E5Q28069487-2F740A44-16A2-4107-BB34-4912A011CC1BQ28260541-2FF66EBC-7420-4499-B82A-5E70C827A618Q30805055-15A3FAFE-47A2-4A64-BCE4-9CD0827CC95BQ30851435-6323B67F-CAE4-4D07-8274-EBD40E8F77C6Q35744096-3D68343D-B3DE-4D65-9F6B-4B8F8264146DQ36148643-8EB9521C-C99A-445B-8826-996783F1F3C6Q36732789-C541CBDE-F154-4661-8065-BEB51310D933Q36840116-1AE3801C-D282-4C0F-BAD2-2B4706D2B4BAQ37122874-ECF1A434-5629-458D-9671-B4E4E7128C6BQ37629039-D1E2D531-B8B0-46F0-97D1-2D5B22916DD9Q38423044-C24D93E1-1002-417B-82C1-D4D526D689D3Q38608107-9CF487A9-60FC-4385-9BE9-D5C9B4679738Q38612793-5F5A76CD-2875-44C4-9BDC-3AC7680321F3Q38622790-116CC9C6-1760-4E7E-BE9E-4ED9410C27FFQ38710288-9E0C5FD2-0145-4527-97F7-B7D2A0150489Q38731776-21CDC643-7129-4E49-ADE0-21E6764ECBB3Q38740000-119BD861-69CE-495D-BC5C-7FC3351B187BQ38817911-4791D083-7EFB-4929-957E-7691D92B26F7Q38822368-72D6B7A0-B9A8-4239-A2B4-F3497B0DAE49Q38909404-8D108FA9-A432-4D6B-AA4A-2DC2B0106845Q38958453-6DCB366E-CDE8-4C1F-B97C-94519C78213FQ40953655-C9C4258E-745D-45D6-86AC-D43D646FD8B2Q41352726-2EBE3BDA-A743-4BD0-A227-D7AA1A5591F2Q41488996-BF483D2D-5625-48A2-8F8C-B56B9E0D56B0Q41573099-5E4D570B-9285-4DA5-BCA8-B32EE9735F2AQ42047956-B06E700B-8512-49C7-BC3C-90726946CEBEQ45893690-77CF2B89-C18D-476E-AF5E-CDA220AA6966Q46136392-61EB7DD1-F8F9-49C0-AAA2-76557E2545D5Q46758501-E9EBEEBD-9A03-4B0E-8927-5940A77883B7Q47159555-EFCD7876-481A-4919-B50F-BE3B7385AA4AQ47243883-75534A88-B407-4568-A4AB-068D418C5A93Q47913337-5FFAC213-B6C3-4BFA-BE43-6E6D830B355D
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Metabolic Dependencies in RAS-Driven Cancers.
@en
type
label
Metabolic Dependencies in RAS-Driven Cancers.
@en
prefLabel
Metabolic Dependencies in RAS-Driven Cancers.
@en
P2860
P1476
Metabolic Dependencies in RAS-Driven Cancers.
@en
P2093
Alec C Kimmelman
P2860
P304
P356
10.1158/1078-0432.CCR-14-2425
P407
P577
2015-04-01T00:00:00Z